Ovarian cancer specimens with positivity or upregulation of S100A14 have been correlated with advanced stage, poor tumor grade, tumor recurrence, resistance to platinum-based therapy and shorter survival probabilities [78, 79, 92]. Here, S100A14 is linked to ovarian cancer.